₹1,034.80
−2.62%NSE close, 16 Nov 2026
+141.02%
ANONDITA MEDICARE is a small cap company, listed on NSE SME under the symbol ANONDITA. At ₹1,034.80 a share, the market values the whole company at ₹1,971 crore. NSE SME is the exchange's platform for small and medium companies, which report their results every half year.
In FY26, it reported sales of ₹137 crore and a net profit of ₹34 crore, an operating margin of 36.9%.
The market values the company at 30.2 times its profit over the last twelve months and 8.21 times its book value; its return on equity is 27.2% and its borrowings are 0.29 times its equity.
Promoters hold 59.26% of the shares. Foreign institutions hold 2.58%, and domestic institutions, mutual funds among them, 6.10%.
Over the past year the share price has risen 70.3%, and it is 21.4% below its 52-week high.
Listed on NSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
₹ crore. Consolidated figures.
| Line | 6M to Sep 2025 | 6M to Mar 2026 | 6M to Sep 2026 |
|---|---|---|---|
| Sales | 54.1 | 83.3 | 73.5 |
| Expenses | 34.9 | 51.9 | 40.9 |
| Operating profit | 19.2 | 31.5 | 32.7 |
| Operating margin | 35.5% | 37.8% | 44.5% |
| Other income | 0.4 | 0.4 |
Presentation for H1 FY2027
Anondita Medicare Limited Reports H1 FY27 Revenue of ₹7,354.17 Lakhs, Up 35.94% YoY; PAT Grows 69.04% to ₹2,200.60 Lakhs
Submission of Monitoring Agency Report for half year ended September 30, 2026
Integrated Standalone and Consolidated Financial Result for half year ended September 30, 2026
Financial Result for half year ended September 30, 2026
The financial results for the period ended September 30, 2026.
Schedule of meet for H1 FY 2027 Earnings Call
| Interest | 1.8 | 1.7 | 2.4 |
|---|
| Depreciation | 0.4 | 0.7 | 1.4 |
|---|
| Profit before tax | 17.4 | 29.5 | 29.5 |
|---|
| Tax | 4.4 | 8.2 | 7.5 |
|---|
| Net profit | 13.0 | 21.3 | 44.0 |
|---|
| EPS (₹) | 9.12 | 11.38 | 11.76 |
|---|
₹ crore, financial years to March.
| Line | FY26 |
|---|---|
| Sales | 137 |
| Expenses | 86.7 |
| Operating profit | 50.7 |
| Operating margin | 36.9% |
| Other income | 0.8 |
| Interest | 3.5 |
| Depreciation | 1.1 |
| Profit before tax | 46.9 |
| Tax | 12.6 |
| Net profit | 34.3 |
| EPS (₹) | 20.77 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY26 | 6M to Sep 2026 |
|---|---|---|
| From operations | 10.6 | −1.7 |
| From investing | −62.7 | −47.9 |
| From financing | 61.3 | 132 |
| Spent on fixed assets | −62.8 | −48.0 |
| Free cash flow | −52.2 | −49.7 |
Margins, returns, debt, tax and cash.
| Line | FY26 |
|---|---|
| Net margin | 25.0% |
| Operating margin | 36.9% |
| Return on equity | 26.5% |
| Return on capital employed | 31.0% |
| Return on assets | 18.6% |
| Debt to equity | 0.26 |
| Interest coverage | 14.20 |
| Debt to assets | 0.18 |
| Current ratio | 3.57 |
| Quick ratio | 2.82 |
| Cash ratio | 0.01 |
| Asset turnover | 0.74 |
| Fixed asset turnover | 3.51 |
| Inventory turnover | 2.90 |
| Receivables turnover | 2.60 |
| Gross margin | 56.3% |
| Cash from operations to profit | 31.0% |
| Effective tax rate | 26.9% |
Anondita Medicare Secures Two CMSS Purchase Orders for Supply of Over 9.80 Crore Condoms
Anondita Medicare expands business across Nepal, Bhutan and Bangladesh through new distribution partnerships
Submission of Certificate in relation to Non- Applicability of Compliance Report on the Corporate Governance under Regulation 27 (2) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, for the Quarter ended September 30, 2026
A copy Srutinizers report of Annual General Meeting held on September 29, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on September 29, 2026